Novartis
(NYSE:NVS)
$87.15
1.21[1.41%]
At close: Aug 9
$87.15
After Hours: 4:16PM EDT
Day High/Low86.91 - 87.74
52 Week High/Low79.09 - 94.26
Open / Close87.04 / 87.15
Float / Outstanding- / 2.2B
Vol / Avg.1.5M / 2.2M
Mkt Cap190.2B
P/E8.43
50d Avg. Price85.15
Div / Yield3.33/3.87%
Payout Ratio32.6
EPS0.77
Total Float-

Novartis (NYSE:NVS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
00000

Analyst Firms Making Recommendations1

  • Wolfe Research

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for Novartis

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

date
Upside/Downside
Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

Novartis Questions & Answers

Q
What is the target price for Novartis (NVS)?
A

The latest price target for Novartis (NYSE: NVS) was reported by Wolfe Research on May 9, 2022. The analyst firm set a price target for $0.00 expecting NVS to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q
What is the most recent analyst rating for Novartis (NVS)?
A

The latest analyst rating for Novartis (NYSE: NVS) was provided by Wolfe Research, and Novartis downgraded their peer perform rating.

Q
When is the next analyst rating going to be posted or updated for Novartis (NVS)?
A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Novartis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Novartis was filed on May 9, 2022 so you should expect the next rating to be made available sometime around May 9, 2023.

Q
Is the Analyst Rating Novartis (NVS) correct?
A

While ratings are subjective and will change, the latest Novartis (NVS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Novartis (NVS) is trading at is $87.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.